Synonyms: 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline; LY-2109761
Molecular Formula: C26H27N5O2
Molecular Weight: 441.52
Linear Structural Formula: C26H27N5O2
MDL Number: MFCD12923354
Purity: >=98% (HPLC)
Storage: -20C
Application: LY2109761 has been used as an inhibitor of type I and II transforming growth factor-beta (TGFß) receptors to reduce the phosphorylation of SMAD2 (mothers against decapentaplegic homolog) in HepG2 cells.
Biochem Physiol Actions: LY2109761 suppresses transforming growth factor (TGF)-ß1-induced fibroblasts proliferation and collagen synthesis in hypertrophic scar fibroblasts. Therefore, it is used in treating hypertrophic scars.